7
Jul 2026
Injectable opioid treatment sees rapid growth across the United States
There was a substantial increase in recent years in the use of a form of the primary medication to treat opioid use disorder, according to a Rutgers Health study.
Stay Informed!
7
Jul 2026
Study offers practical guidance for future mRNA vaccine patch design
New research could help make future mRNA vaccines easier to store and distribute.
7
Jul 2026
Gut immune cells help prevent severe salmonella infections
Widely recognized as the face of food poisoning, salmonella bacteria lurk in raw meat and poultry, on pets and in unpasteurized dairy products.
7
Jul 2026
Infrared imaging improves at-home eczema hydration monitoring
Diagnosis and management of atopic dermatitis, a type of eczema, are complicated by skin temperature fluctuations, unclear responses to at-home moisturizers, and measurement systems that don't penetrate into the deep layers of skin affected by disease.
7
Jul 2026
New review shows why antidepressants often fail in Alzheimer’s and Parkinson’s depression
A Molecular Psychiatry review shows that depression in Alzheimer’s and Parkinson’s disease may reflect disease-specific molecular, neurotransmitter, inflammatory, and circuit-level disruptions rather than standard depression biology alone. It argues that broad antidepressants often show limited efficacy in these patients and that future trials should use biomarkers, neuroimaging, and symptom profiling to guide targeted treatments.
7
Jul 2026
Researchers develop low-cost catnip mosquito repellent for rural Uganda
Plant researchers from Wales and Uganda have collaborated on a community enterprise project in rural Uganda, becoming the first to create affordable and highly effective mosquito repellent distilled from locally grown catnip plants.
7
Jul 2026
New study explores health effects of hookah smoking methods
Hookah is often seen as a cleaner alternative to smoking cigarettes, but researchers at The University of Texas at Arlington are launching a new study to put that assumption to the test.
7
Jul 2026
Updated ABCs framework gives clinicians a clearer path to prevent heart disease
A 2026 State-of-the-Art review updates the ABCs of cardiovascular disease prevention to help clinicians apply contemporary risk assessment, lifestyle, pharmacologic, and cardiometabolic strategies in routine care. The framework emphasizes PREVENT™ risk equations, Life’s Essential 8, CKM syndrome, obesity care, lipid lowering, blood pressure control, healthy aging, heart failure prevention, and atrial fibrillation management.
7
Jul 2026
Study reveals why patients with rare leukemia develop resistance to tagraxofusp
Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-approved treatment for this disease.
7
Jul 2026
Novel leukemia therapy successfully eradicates measurable residual disease
Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in B-cell acute lymphoblastic leukemia (ALL) patients, a critical step in improving long-term survival outcomes, by treating with the antibody-drug conjugate (ADC) inotuzumab ozogamicin.
